Percutaneous Fine Needle Biopsy in Pancreatic Tumors: A Study of 42 Cases

The technological progress within the range of methods of pancreas imaging and their more common accessibility selects a group of patients requiring a microscopic diagnosis. Percutaneous fine needle aspiration biopsy under the control of ultrasonography (PCFNA/USG) is the method commonly used in de...

Full description

Saved in:
Bibliographic Details
Main Authors: Piotr Lewitowicz, Jaroslaw Matykiewicz, Jacek Heciak, Dorota Koziel, Stanisław Gluszek
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2012/908963
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567280090742784
author Piotr Lewitowicz
Jaroslaw Matykiewicz
Jacek Heciak
Dorota Koziel
Stanisław Gluszek
author_facet Piotr Lewitowicz
Jaroslaw Matykiewicz
Jacek Heciak
Dorota Koziel
Stanisław Gluszek
author_sort Piotr Lewitowicz
collection DOAJ
description The technological progress within the range of methods of pancreas imaging and their more common accessibility selects a group of patients requiring a microscopic diagnosis. Percutaneous fine needle aspiration biopsy under the control of ultrasonography (PCFNA/USG) is the method commonly used in determining the character of a focal pancreatic lesion. Aim of the Work. An assessment of the accessibility of PCFNA biopsy in the assessment of solid and cystic changes in a pancreas and the correlation of the results of imaging examination, cytological smear and concentration of a serous marker CA19-9. Material and Methodology. In our material we analysed 43 cases of tumors of the pancreas among the patients who were at the average age of 59 ± 10.4 (14 women, 28 men) diagnosed by PCFNA biopsy. Results. In a group we are 23 cases of cancer, 12 cases of inflammation and 7 cases of cellular atypia for which 2 cases of IPMN were included. The sensitivity of the method was 92.5% but specificity was 68%. In our opinion PCFNA/USG is a method of the comparable sensitivity and specificity with fine needle aspiration biopsy with EUS control and its efficiency depends to a considerable degree on experience and interdisciplinary collaboration.
format Article
id doaj-art-ff7f8dbd4d394de088874fb2c5d6fd96
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-ff7f8dbd4d394de088874fb2c5d6fd962025-02-03T01:01:58ZengWileyGastroenterology Research and Practice1687-61211687-630X2012-01-01201210.1155/2012/908963908963Percutaneous Fine Needle Biopsy in Pancreatic Tumors: A Study of 42 CasesPiotr Lewitowicz0Jaroslaw Matykiewicz1Jacek Heciak2Dorota Koziel3Stanisław Gluszek4Department of Pathology, University of Jan Kochanowski (UJK), Al. IX Wieków Kielc 19, 25-317 Kielce, PolandDepartment of Surgery and Surgical Nursing, University of Jan Kochanowski (UJK), Al. IX Wieków Kielc 19, 25-317 Kielce, PolandDepartment of Radiology, Joint Provincial Hospital Kielce, ul. Grunwaldzka 45, 25-736 Kielce, PolandDepartment of Surgery and Surgical Nursing, University of Jan Kochanowski (UJK), Al. IX Wieków Kielc 19, 25-317 Kielce, PolandDepartment of Surgery and Surgical Nursing, University of Jan Kochanowski (UJK), Al. IX Wieków Kielc 19, 25-317 Kielce, PolandThe technological progress within the range of methods of pancreas imaging and their more common accessibility selects a group of patients requiring a microscopic diagnosis. Percutaneous fine needle aspiration biopsy under the control of ultrasonography (PCFNA/USG) is the method commonly used in determining the character of a focal pancreatic lesion. Aim of the Work. An assessment of the accessibility of PCFNA biopsy in the assessment of solid and cystic changes in a pancreas and the correlation of the results of imaging examination, cytological smear and concentration of a serous marker CA19-9. Material and Methodology. In our material we analysed 43 cases of tumors of the pancreas among the patients who were at the average age of 59 ± 10.4 (14 women, 28 men) diagnosed by PCFNA biopsy. Results. In a group we are 23 cases of cancer, 12 cases of inflammation and 7 cases of cellular atypia for which 2 cases of IPMN were included. The sensitivity of the method was 92.5% but specificity was 68%. In our opinion PCFNA/USG is a method of the comparable sensitivity and specificity with fine needle aspiration biopsy with EUS control and its efficiency depends to a considerable degree on experience and interdisciplinary collaboration.http://dx.doi.org/10.1155/2012/908963
spellingShingle Piotr Lewitowicz
Jaroslaw Matykiewicz
Jacek Heciak
Dorota Koziel
Stanisław Gluszek
Percutaneous Fine Needle Biopsy in Pancreatic Tumors: A Study of 42 Cases
Gastroenterology Research and Practice
title Percutaneous Fine Needle Biopsy in Pancreatic Tumors: A Study of 42 Cases
title_full Percutaneous Fine Needle Biopsy in Pancreatic Tumors: A Study of 42 Cases
title_fullStr Percutaneous Fine Needle Biopsy in Pancreatic Tumors: A Study of 42 Cases
title_full_unstemmed Percutaneous Fine Needle Biopsy in Pancreatic Tumors: A Study of 42 Cases
title_short Percutaneous Fine Needle Biopsy in Pancreatic Tumors: A Study of 42 Cases
title_sort percutaneous fine needle biopsy in pancreatic tumors a study of 42 cases
url http://dx.doi.org/10.1155/2012/908963
work_keys_str_mv AT piotrlewitowicz percutaneousfineneedlebiopsyinpancreatictumorsastudyof42cases
AT jaroslawmatykiewicz percutaneousfineneedlebiopsyinpancreatictumorsastudyof42cases
AT jacekheciak percutaneousfineneedlebiopsyinpancreatictumorsastudyof42cases
AT dorotakoziel percutaneousfineneedlebiopsyinpancreatictumorsastudyof42cases
AT stanisławgluszek percutaneousfineneedlebiopsyinpancreatictumorsastudyof42cases